BlackRock, Inc. 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Sale |
2024-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
9,884,617 16.600% |
-779,078 (-7.31%) |
Filing |
| 2024-08-07 4:10 pm Purchase |
2024-07-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
10,663,695 18.200% |
5,119,793 (+92.35%) |
Filing |
| 2024-01-24 2:27 pm Purchase |
2023-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
5,543,902 9.600% |
1,891,745 (+51.80%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
3,652,157 7.400% |
370,521 (+11.29%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
3,281,636 6.900% |
689,925 (+26.62%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
2,591,711 6.200% |
935,470 (+56.48%) |
Filing |
| 2020-06-09 4:32 pm Purchase |
2020-05-31 | 13G | Protagonist Therapeutics, Inc. PTGX |
BLACKROCK INC BLK |
1,656,241 4.800% |
94,284 (+6.04%) |
Filing |